Anna C. Ferrari
- Oncology top 0.5%
- Immunology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 5%
- Cancer Research top 2%
- Co-authors
- Celestia S. HiganoPhilip W. KantoffMark W. FrohlichNeal D. ShoreEric J. SmallDavid F. PensonRobert DreicerYi Xu
- Topics
- Prostate Cancer Treatment and Research (37 papers)Cancer, Lipids, and Metabolism (11 papers)Radiopharmaceutical Chemistry and Applications (7 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Anna C. Ferrari
55 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Oncology 2.8k
- Immunology 2.4k
- Pulmonary and Respiratory Medicine 2.3k
- Molecular Biology 2.2k
- Cancer Research 851
Countries citing papers authored by Anna C. Ferrari
This map shows the geographic impact of Anna C. Ferrari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna C. Ferrari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna C. Ferrari more than expected).
Fields of papers citing papers by Anna C. Ferrari
This network shows the impact of papers produced by Anna C. Ferrari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna C. Ferrari. The network helps show where Anna C. Ferrari may publish in the future.
Co-authorship network of co-authors of Anna C. Ferrari
This figure shows the co-authorship network connecting the top 25 collaborators of Anna C. Ferrari. A scholar is included among the top collaborators of Anna C. Ferrari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna C. Ferrari. Anna C. Ferrari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 23 | |
| 3 | 1 | |
| 4 | 52 | |
| 5 | 18 | |
| 6 | 2 | |
| 7 | 28 | |
| 8 | Optimal timing of sipuleucel-T treatment in metastatic castration-resistant prostate cancer. | 10 |
| 9 | 25 | |
| 10 | 23 | |
| 11 | 91 | |
| 12 | 128 | |
| 13 | 8 | |
| 14 | Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancerbreakdown → | 4077 |
| 15 | 97 | |
| 16 | 42 | |
| 17 | 13 | |
| 18 | 53 | |
| 19 | 97 | |
| 20 | 47 |
About Anna C. Ferrari
Anna C. Ferrari is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 56 papers that have together received 5.9k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (37 papers), Cancer, Lipids, and Metabolism (11 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Immunology (2.4k citations), Oncology (2.8k citations) and Pulmonary and Respiratory Medicine (2.3k citations). Anna C. Ferrari has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Celestia S. Higano, Philip W. Kantoff, Mark W. Frohlich, Neal D. Shore, Eric J. Small, David F. Penson, Robert Dreicer, Yi Xu, E. Roy Berger and Charles H. Redfern. Their work appears in journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.